These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39505123)

  • 1. Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HF.
    Shoji S; Cyr DD; Hernandez AF; Velazquez EJ; Ward JH; Williamson KM; Sarwat S; Starling RC; Desai AS; Zieroth S; Solomon SD; Mentz RJ
    Am Heart J; 2025 Feb; 280():70-78. PubMed ID: 39505123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.
    Shaddy R; Burch M; Kantor PF; Solar-Yohay S; Garito T; Zhang S; Kocun M; Mao C; Cilliers A; Wang X; Canter C; Rossano J; Wallis G; Menteer J; Daou L; Kusa J; Tokel K; Dilber D; Xu Z; Xiao T; Halnon N; Daly KP; Bock MJ; Zuckerman W; Singh TP; Chakrabarti M; Levitas A; Senni M; Grutter G; Kim GB; Song J; Lee HD; Chen CK; Sanchez-de-Toledo J; Law Y; Wanitkun S; Cui Y; Anjos R; Mese T; Bonnet D;
    Circulation; 2024 Nov; 150(22):1756-1766. PubMed ID: 39319469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials.
    Lu H; Claggett BL; Packer M; Lam CSP; Swedberg K; Rouleau J; Zile MR; Lefkowitz M; Desai AS; Jhund P; McMurray JJV; Solomon SD; Vaduganathan M
    JAMA Cardiol; 2024 Nov; 9(11):1047-1052. PubMed ID: 39210725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study.
    Palazzuoli A; Pirrotta F; Cartocci A; Delcuratolo E; Dini FL; Correale M; Dattilo G; Masarone D; Scelsi L; Ghio S; Tocchetti CG; Mercurio V; Brunetti ND; Nodari S; Barillà F; Ambrosio G; Carluccio E
    Ther Adv Cardiovasc Dis; 2024; 18():17539447241285136. PubMed ID: 39611607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction.
    Stegmann T; Parentin L; Schirmer SH; Lavall P; Hagendorff A; Laufs U; Lavall D
    Am J Physiol Heart Circ Physiol; 2024 Dec; 327(6):H1477-H1489. PubMed ID: 39453422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized Clinical Trials.
    Butt JH; McMurray JJV; Claggett BL; Jhund PS; Neuen BL; McCausland FR; Desai AS; Lam CSP; Pitt B; Pfeffer MA; Packer M; Beldhuis IE; Voors AA; Zannad F; Heerspink HJL; Solomon SD; Vaduganathan M
    Circulation; 2024 Dec; 150(23):1858-1868. PubMed ID: 39217458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of beta-blocker use by N-terminal pro-brain natriuretic peptide level in acute heart failure patients.
    Kim SJ; Ann SH; Park GM; Kim YG; Park S; Lee SG
    ESC Heart Fail; 2024 Dec; 11(6):3842-3853. PubMed ID: 39015043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus.
    Ianos RD; Iancu M; Pop C; Lucaciu RL; Hangan AC; Rahaian R; Cozma A; Negrean V; Mercea D; Procopciuc LM
    Medicina (Kaunas); 2024 Nov; 60(11):. PubMed ID: 39597026
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
    Shen L; Dewan P; Ferreira JP; Cunningham JW; Jhund PS; Anand IS; Chandra A; Chiang LM; Claggett B; Desai AS; Gong J; Lam CSP; Lefkowitz MP; Maggioni AP; Martinez F; Packer M; Redfield MM; Rouleau JL; van Veldhuisen DJ; Zannad F; Zile MR; Solomon SD; McMurray JJV
    Circulation; 2024 Dec; 150(24):1913-1927. PubMed ID: 39429145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction.
    Moraña-Fernández S; Vázquez-Abuín X; Aragón-Herrera A; Anido-Varela L; García-Seara J; Otero-García Ó; Rodríguez-Penas D; Campos-Toimil M; Otero-Santiago M; Rodrigues A; Gonçalves A; Pereira Morais J; Alves IN; Sousa-Mendes C; Falcão-Pires I; González-Juanatey JR; Feijóo-Bandín S; Lago F
    Biochem Pharmacol; 2024 Dec; 230(Pt 1):116571. PubMed ID: 39424202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM-HF study.
    Mebazaa A; Davison BA; Biegus J; Edwards C; Murtagh G; Varounis C; Hayrapetyan H; Sisakian H; Ter-Grigoryan VR; Takagi K; Novosadova M; Ponikowski P; Cotter G
    Eur J Heart Fail; 2024 Jul; 26(7):1507-1517. PubMed ID: 38721803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of first-line antihypertensive drug class and intensity on NT-proBNP improvement and cardiovascular outcomes among hypertensive patients with pre-heart failure: findings from SPRINT trial.
    Wang L; Yi J; Wang W; Zhou Z; Liu J; Zhang H; Li Y; Ren X; Lu J; Zheng X
    Hypertens Res; 2024 Dec; 47(12):3447-3457. PubMed ID: 39358594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming pediatric heart failure: Efficacy of low-dose sacubitril/valsartan.
    Zha H; Zhai X; Wang L; Yang Q; Guo Q; Chen Y; Liu J; Peng H
    Curr Probl Cardiol; 2025 Jan; 50(1):102926. PubMed ID: 39510399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial.
    Rohde LE; Rover MM; Hoffmann Filho CR; Rabelo-Silva ER; Silvestre OM; Martins SM; Passos LCS; de Figueiredo Neto JA; Danzmann LC; Silveira FS; Mesas CE; Hernandes ME; Moura LZ; Simões MV; Ritt LEF; Nishijuka FA; Bertoldi EG; Dall Orto FTC; Magedanz EH; Mourilhe-Rocha R; Fernandes-Silva MM; Ferraz AS; Schwartzmann P; de Castilho FM; Pereira Barretto AC; Dos Santos Júnior EG; Nogueira PR; Canesin M; Beck-da-Silva L; de Carvalho Silva M; Adolfi Júnior MS; Santos RHN; Ferreira A; Pereira D; López Pedraza L; Kojima FCS; Campos V; de Barros E Silva PGM; Blacher M; Cavalcanti AB; Ramires F;
    JAMA Cardiol; 2024 Feb; 9(2):105-113. PubMed ID: 38055237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.